Since treatment with ACVR1 inhibitors markedly prolonged the survival of DIPG mice71–73, brain-transducible AAV9-mediated gene therapy for FOP might be also useful to treat tumorigenesis of DIPG. The gene discussed is ACVR1; the disease is fibrodysplasia ossificans progressiva.